Clinical Trials Logo

Children, Adult clinical trials

View clinical trials related to Children, Adult.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05629013 Recruiting - Mental Health Issue Clinical Trials

TEAMS R34 #1 After-Action Reviews in Child Welfare Services

R34-1
Start date: July 28, 2023
Phase: N/A
Study type: Interventional

This project proposes to improve successful mental health service linkage in Child Welfare Services (CWS) by adapting and testing the After Action Review (AAR) team effectiveness intervention to augment the Child Family Team (CFT) services intervention. Despite being both required and a collaborative approach to service planning, CFT meetings are implemented with questionable fidelity and consistency, rarely including children and families as intended. By inclusion of child and family voice, the AAR-enhanced CFT should lead to increased fidelity to the CFT intervention and greater levels of parental satisfaction with the service and shared decision-making, thus resulting in enhanced follow-through with Action Plans and linkage to mental health care for children.

NCT ID: NCT05055830 Recruiting - Cardiac Disease Clinical Trials

Opportunistic PK/PD Trial in Critically Ill Children (OPTIC)

OPTIC
Start date: October 5, 2021
Phase:
Study type: Observational

OPTIC is a prospective, open-label, non-randomized study of multiple medications administered to approximately 2000 children in the pediatric cardiac intensive care unit (PCICU) per routine clinical car by their treating provider. The purpose of this study is to characterize the PK of drugs routinely administered to children per standard of care using opportunistic and scavenged samples. The prescribing of drugs to children will not be part of this protocol. After the child/adult (<21 years of age) is consented/enrolled, demographic and clinical data will be extracted from the EHR. Biospecimen information (including date and time of sample collection) will be collected. Data analysis will be conducted on all participants with at least 2 evaluable samples. The protocol represents minimal risk to the children/adults who provide body fluid for this study, including potential loss of confidentiality (samples will be assigned a unique accession number) and risks associated with blood draws. Adverse Events (AEs)/Serious Adverse Events (SAEs) caused by the study specimen collections will be monitored and recorded in the Electronic Data Capture (EDC) system.